$LLY.d
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Stocks
$1,086
▼2.48%from 30d ago
$1,121
▼7.62%from 30d ago
18
▲+20.00%from 30d ago
$0.00
Tokenized Stock Metrics
Metric
Show % of Total
Market Cap by Network
as of 08/04/2026
Key Facts
Name
Eli Lilly & Co.
Ticker
LLY.d
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
11/13/2023
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$1,086
▼
NAV
$1,121
▼
Price
—
Token Supply
0.97
▲
Circulating Supply
0.97
▲
7D APY
—
30D APY
—
Holders
18
▲
Trailing 30D Active Addresses
—
Monthly Transfer Count
2
▼
Monthly Transfer Volume
$0
△
Tokens
Primary Market
Eligible Investors
—
Base Assets
—
Subscription Time
—
Min. Investment
—
Subscription Fees
0%
Subscription Description
—
Redemption Time
—
Minimum Redemption Amount
—
Redemption Fees
0%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
Dinari
Issuer LEI
—
Issuer CIK
Domicile
United States of America
Regulatory Framework
U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0%
Subscription Fees
0%
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
Holders Product Screenshot
RWA.xyzAll Rights Reserved